LaSalle Street Capital Management, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 141 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.

Quarter-by-quarter ownership
LaSalle Street Capital Management, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$261,000
-2.2%
3,445
-32.1%
0.26%
+23.2%
Q1 2018$267,000
-5.7%
5,070
-4.3%
0.21%
+8.2%
Q4 2017$283,000
+3.7%
5,296
+15.7%
0.20%
-3.0%
Q3 2017$273,000
-8.7%
4,576
+7.0%
0.20%
-27.2%
Q3 2016$299,000
-1.6%
4,278
-45.5%
0.28%
-4.8%
Q2 2016$304,0007,8460.29%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 400,000$5,732,0001.52%
Park West Asset Management LLC 426,900$6,117,0000.80%
WALL STREET ASSOCIATES 200,000$2,866,0000.25%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 284,653$4,079,0000.16%
FARALLON CAPITAL MANAGEMENT LLC 100,000$1,433,0000.02%
NEXT Financial Group, Inc 2,500$26,0000.01%
PIPER SANDLER & CO. 1,277$18,0000.01%
Ground Swell Capital, LLC 400$6,0000.01%
PARADIGM ASSET MANAGEMENT CO LLC 6,300$90,279,0000.01%
Paloma Partners Management Co 14,363$206,0000.01%
View complete list of EAGLE PHARMACEUTICALS INC shareholders